注意欠陥多動性障害（ADHD）治療薬の世界市場レポート2020

• 英文タイトル：Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Report 2020

• レポートコード：MRC2102QY0972 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYリサーチ社の本調査レポートでは、世界の注意欠陥多動性障害（ADHD）治療薬市場について種類別（覚醒剤、非覚醒剤）、用途別（小児科、青年期、成人）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・注意欠陥多動性障害（ADHD）治療薬市場の概要 ・世界の主要地域別注意欠陥多動性障害（ADHD）治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の注意欠陥多動性障害（ADHD）治療薬市場規模2015-2026：種類別（覚醒剤、非覚醒剤） ・世界の注意欠陥多動性障害（ADHD）治療薬市場規模2015-2026：用途別（小児科、青年期、成人） ・注意欠陥多動性障害（ADHD）治療薬の米国市場規模2015-2020 ・注意欠陥多動性障害（ADHD）治療薬のヨーロッパ市場規模2015-2020 ・注意欠陥多動性障害（ADHD）治療薬の中国市場規模2015-2020 ・注意欠陥多動性障害（ADHD）治療薬の日本市場規模2015-2020 ・注意欠陥多動性障害（ADHD）治療薬の東南アジア市場規模2015-2020 ・注意欠陥多動性障害（ADHD）治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・注意欠陥多動性障害（ADHD）治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・注意欠陥多動性障害（ADHD）治療薬の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market
The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Scope and Market Size
The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder (ADHD) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Attention Deficit Hyperactivity Disorder (ADHD) Drug market is segmented into
Stimulants
Non-Stimulants

Segment by Application, the Attention Deficit Hyperactivity Disorder (ADHD) Drug market is segmented into
Pediatric
Adolescent
Adults

The Attention Deficit Hyperactivity Disorder (ADHD) Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Attention Deficit Hyperactivity Disorder (ADHD) Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share Analysis
Attention Deficit Hyperactivity Disorder (ADHD) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Attention Deficit Hyperactivity Disorder (ADHD) Drug business, the date to enter into the Attention Deficit Hyperactivity Disorder (ADHD) Drug market, Attention Deficit Hyperactivity Disorder (ADHD) Drug product introduction, recent developments, etc.

The major vendors covered:
Eli Lilly
Perdue Pharma
Johnson & Johnson
Janssen Pharmaceuticals, Inc.
Takeda
Glaxosmith Kline
Novartis
Celltech Group

レポート目次

---

1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Overview
1.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Scope
1.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Segment by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales by Type (2020-2026)
1.2.2 Stimulants
1.2.3 Non-Stimulants
1.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Segment by Application
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Comparison by Application (2020-2026)
1.3.2 Pediatric
1.3.3 Adolescent
1.3.4 Adults
1.4 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Growth Rate (2015-2026)
1.4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price Trends (2015-2026)

2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimate and Forecast by Region
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Region (2015-2020)
2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimates and Projections (2015-2026)
2.4.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimates and Projections (2015-2026)
2.4.3 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimates and Projections (2015-2026)
2.4.4 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimates and Projections (2015-2026)
2.4.6 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Estimates and Projections (2015-2026)
3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Competition Landscape by Players
3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Drug Players by Sales (2015-2020)
3.2 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Drug Players by Revenue (2015-2020)
3.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Drug as of 2019)
3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Average Price by Company (2015-2020)
3.5 Manufacturers Attention Deficit Hyperactivity Disorder (ADHD) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Attention Deficit Hyperactivity Disorder (ADHD) Drug Players (Opinion Leaders)
4 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price by Type (2015-2020)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price Forecast by Type (2021-2026)
5 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size by Application
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price by Application (2015-2020)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price Forecast by Application (2021-2026)

6 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Facts & Figures
6.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
6.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
6.3 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)

7 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Facts & Figures
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)

8 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Facts & Figures
8.1 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
8.2 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
8.3 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)

9 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Facts & Figures
9.1 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (3015-3030)
9.2 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
9.3 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)

10 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Facts & Figures
10.1 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)

11 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Facts & Figures
11.1 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
11.2 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
11.3 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Attention Deficit Hyperactivity Disorder (ADHD) Drug Business
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Business Overview
12.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Perdue Pharma
12.2.1 Perdue Pharma Corporation Information
12.2.2 Perdue Pharma Business Overview
12.2.3 Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.2.5 Perdue Pharma Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Janssen Pharmaceuticals, Inc.
12.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
12.4.2 Janssen Pharmaceuticals, Inc. Business Overview
12.4.3 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.4.5 Janssen Pharmaceuticals, Inc. Recent Development
12.5 Takeda
12.5.1 Takeda Corporation Information
12.5.2 Takeda Business Overview
12.5.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.5.5 Takeda Recent Development
12.6 Glaxosmith Kline
12.6.1 Glaxosmith Kline Corporation Information
12.6.2 Glaxosmith Kline Business Overview
12.6.3 Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.6.5 Glaxosmith Kline Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Business Overview
12.7.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.7.5 Novartis Recent Development
12.8 Celltech Group
12.8.1 Celltech Group Corporation Information
12.8.2 Celltech Group Business Overview
12.8.3 Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Products Offered
12.8.5 Celltech Group Recent Development

13 Attention Deficit Hyperactivity Disorder (ADHD) Drug Manufacturing Cost Analysis
13.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
13.4 Attention Deficit Hyperactivity Disorder (ADHD) Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Distributors List
14.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Customers

15 Market Dynamics
15.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Trends
15.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Opportunities and Drivers
15.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Challenges
15.4 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Region (2015-2020)
Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Region (2015-2020)
Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Company (2015-2020)
Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Company (2015-2020)
Table 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Drug as of 2019)
Table 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Attention Deficit Hyperactivity Disorder (ADHD) Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Attention Deficit Hyperactivity Disorder (ADHD) Drug Players
Table 22. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Type (2015-2020)
Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Type (2021-2026)
Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Type (2021-2026)
Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Application (2015-2020)
Table 32. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Application (2021-2026)
Table 36. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Application (2021-2026)
Table 38. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
Table 41. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 43. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 51. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
Table 53. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 55. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)
Table 69. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company (2015-2020)
Table 71. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type (2015-2020)
Table 73. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2015-2020)
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 79. Eli Lilly Recent Development
Table 80. Perdue Pharma Corporation Information
Table 81. Perdue Pharma Description and Business Overview
Table 82. Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 84. Perdue Pharma Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 89. Johnson & Johnson Recent Development
Table 90. Janssen Pharmaceuticals, Inc. Corporation Information
Table 91. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 92. Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 94. Janssen Pharmaceuticals, Inc. Recent Development
Table 95. Takeda Corporation Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 99. Takeda Recent Development
Table 100. Glaxosmith Kline Corporation Information
Table 101. Glaxosmith Kline Description and Business Overview
Table 102. Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 104. Glaxosmith Kline Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 109. Novartis Recent Development
Table 110. Celltech Group Corporation Information
Table 111. Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Celltech Group Description and Business Overview
Table 113. Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Product
Table 114. Celltech Group Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Attention Deficit Hyperactivity Disorder (ADHD) Drug Distributors List
Table 118. Attention Deficit Hyperactivity Disorder (ADHD) Drug Customers List
Table 119. Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Key Trends
Table 120. Attention Deficit Hyperactivity Disorder (ADHD) Drug Key Opportunities and Drivers
Table 121. Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Picture
Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share by Application in 2020 & 2026
Figure 6. Pediatric Examples
Figure 7. Adolescent Examples
Figure 8. Adults Examples
Figure 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Attention Deficit Hyperactivity Disorder (ADHD) Drug Players Market Share by Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Drug 2015 & 2019
Figure 27. Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Type (2015-2020)
Figure 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Application (2015-2020)
Figure 31. Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 33. United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company in 2019
Figure 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application in 2019
Figure 37. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company in 2019
Figure 38. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 39. China Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application in 2019
Figure 40. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company in 2019
Figure 41. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 42. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application in 2019
Figure 46. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Company in 2019
Figure 47. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2019
Figure 48. India Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure 51. Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure 52. Attention Deficit Hyperactivity Disorder (ADHD) Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

---